Live Breaking News & Updates on Company investigational new drug

Stay informed with the latest breaking news from Company investigational new drug on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Company investigational new drug and stay connected to the pulse of your community

Ocugen, Inc. Announces U.S. FDA Clearance of IND Amendment to Initiate OCU400 Phase 3 Clinical Trial — First Gene Therapy to Enter Phase 3 with a Broad Retinitis Pigmentosa Indication

MALVERN, Pa., April 08, 2024 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the...

United-states , Arun-upadhyay , Shankar-musunuri , Ocugen-inc , Linkedin , Drug-administration , Exchange-commission , Company-investigational-new-drug , Head-of-communications , Investigational-new-drug , Multi-luminance-mobility-testing , Luminance-dependent-navigation-assessment

Ocugen, Inc. Announces U.S. FDA Clearance of IND Amendment to Initiate OCU400 Phase 3 Clinical Trial

Ocugen, Inc. Announces U.S. FDA Clearance of IND Amendment to Initiate OCU400 Phase 3 Clinical Trial
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Drug-administration , Ocugen-inc , Company-investigational-new-drug , Investigational-new-drug ,

Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update

Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Japan , United-states , Spain , United-kingdom , Boston , Massachusetts , Italy , Italian , Japanese , David-connolly , Adam-daley , David-meeker

Krystal Biotech Receives FDA Fast Track Designation for Inhaled Oncology Candidate KB707 to Treat Solid Tumors of the Lung

Krystal Biotech Receives FDA Fast Track Designation for Inhaled Oncology Candidate KB707 to Treat Solid Tumors of the Lung
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Pennsylvania , United-states , Suma-krishnan , Daniel-johnson , Exchange-commission , Krystal-biotech-inc , Ochsner-md-anderson-cancer-center-medical , Research-development , Company-investigational-new-drug , Nasdaq , Drug-administration , Twitter

Krystal Biotech (KRYS) Granted FDA Fast Track Designation for KB707

Krystal Biotech (KRYS) Granted FDA Fast Track Designation for KB707
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Daniel-johnson , Suma-krishnan , Company-investigational-new-drug , Drug-administration , Krystal-biotech-inc , Research-development , Ochsner-md-anderson-cancer-center-medical , Krystal-biotech , Fast-track-designation , Innovative-cancer-therapies , Cancer-center-medical , New-orleans

Rhythm Pharmaceuticals Announces Completion of Screening

-- Phase 3 hypothalamic obesity top-line data expected in 1H2025 -- -- Positive reimbursement decision achieved for IMCIVREE® (setmelanotide) to treat...

Spain , United-kingdom , Boston , Massachusetts , United-states , David-meeker , Yann-mazabraud , David-connolly , Adam-daley , Nasdaq , Ministry-of-health , Rhythm-pharmaceuticals-inc

Rhythm Pharmaceuticals Announces Completion of Screening for Enrollment in Setmelanotide Phase 3 Hypothalamic Obesity Trial and Additional Updates

-- Phase 3 hypothalamic obesity top-line data expected in 1H2025 -- -- Positive reimbursement decision achieved for IMCIVREE® to treat patients with Bardet-Biedl syndrome and POMC/LEPR...

United-kingdom , United-states , Boston , Massachusetts , Spain , Adam-daley , Yann-mazabraud , David-connolly , David-meeker , Corporate-communications , United-kingdom-medicines-healthcare-products-regulatory-agency , Berry-company-public-relations

Rhythm Pharmaceuticals (RYTM) Provides Business Update

Rhythm Pharmaceuticals (RYTM) Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , United-states , Boston , Massachusetts , Spain , David-meeker , Yann-mazabraud , Rhythm-pharmaceuticals-inc , Head-of-international-at-rhythm , Nasdaq , European-union , Ministry-of-health

GRI Bio Says FDA Clears IND For GRI-0621 For Treatment Of IPF; Stock Up 19%

Biotechnology company GRI Bio, Inc. (GRI) announced Monday that the U.S. Food and Drug Administration has cleared the Company's Investigational New Drug (IND) application for GRI-0621 for the treatment of IPF.

Company-investigational-new-drug , Bio-inc , Drug-administration , Investigational-new-drug , Investigational-new-drug- , Ri , Ri-bio , Iotechnology-company-gri-bio , Ri-0621 ,

GRI Bio, Inc (GRI) Announces FDA Clearance of IND for Lead Program GRI-0621

GRI Bio, Inc (GRI) Announces FDA Clearance of IND for Lead Program GRI-0621
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Marc-hertz , Nasdaq , Gri-bio-inc , Drug-administration , Company-investigational-new-drug , Investigational-new-drug , Chief-executive-officer ,